Kingdom Investment Holdings

09/08/2025

Back-to-back nights at Dave & Buster’s 🎯🎮 … Bassagel™ jerseys one night, SubMagna® HMW jerseys the next. One out of three daughters, two sons, and one grandson in tow — and plenty of exposure for www.bassagel.com & www.submagna.com
thanks to the jerseys! 👕✨

SubMagna HMW Bassagel Richie's Specialty Pharmacy

08/26/2025

https://www.pccainternationalseminar.com/

Want to learn more about ever broadening SubMagna HMW usage in compounded drug products? Attend PCCA International 2025!

Compounded medications are not reviewed by FDA for safety or efficacy.

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.

08/24/2025

Any PCCA member or any Kingdom Licensing Licensee (www.kingdomlicensing.com) has access to BASSAGEL as well as the APIs (Benzocaine, Lidocaine and Tetracaine). The APIs could be obtained from other chemical wholesalers as well. Obtaining BASSAGEL is solely from PCCA or Kingdom Distribution.

BASSAGEL™ is a water-washable, pharmacist-designed moisturizing ointment used for dry skin, wound care, tattoo aftercare, diaper rash, acne, and more. Gentle, versatile, and easy to remove.

08/19/2025

🚨 Patent Power Alert 🚨

Kingdom Licensing is stacking innovation like never before! Their latest U.S. Patent No. 12,370,160 B2, issued July 29, 2025, covers advanced compounded compositions for pain relief - think lidocaine, diclofenac, and prilocaine in one powerful topical formula 💥.

With each new patent, their portfolio keeps expanding, solidifying their position as a leader in pharmaceutical compounding IP. This isn’t just a win—it’s momentum.

Compounded medications are not reviewed by FDA for safety or efficacy.

www.kingdomlicensing.com
www.kih-llc.com

08/12/2025

08/06/2025

08/01/2025

Discover a compounded formulation of Semaglutide for sublingual administration, an innovative choice for healthcare professionals and patients seeking a non-injection option.

08/01/2025

07/31/2025

Pharmacies, healthcare providers, hair stylists, and others across the country are embracing this approach. Take a look and see why it’s gaining traction!

www.kih-llc.com

07/31/2025

Pharmacies that are licensees of Kingdom Licensing (www.kingdomlicensing.com) and so many others are evaluating the idea of compounded Semaglutide and NAD together. Check out the link to learn more!

Compounded medications are not reviewed by FDA for safety or efficacy.

Discover a compounded formulation of Semaglutide for sublingual administration, an innovative choice for healthcare professionals and patients seeking a non-injection option.

07/27/2025

🚀 Repost Spotlight: Amazing share about SubMagna® HMW!

Did you know? Any compounding pharmacy in the U.S. can access SubMagna® HMW - either by being a PCCA member or by becoming a licensee of Kingdom Licensing, LLC (www.kingdomlicensing.com).

That means there’s no barrier for independent and institutional pharmacies to utilize this cutting-edge sublingual suspension base for enhanced absorption of vitamins, hormones, peptides, ED agents, collagen, GLP-1s and more.

For pharmacies:

Join PCCA to gain access directly, or

Become a Kingdom Licensing licensee - both options unlock SubMagna® HMW for compounding.

For prescribers and patients:

Ask your favorite compounding pharmacy today if they’re using SubMagna® HMW.

If they’re not yet compounding with it, recommend they consider PCCA membership or Kingdom Licensing.

07/25/2025

🚨 Breaking: Legal Setback for Novo Nordisk’s Wegovy® 🚨

In a major patent ruling out of Delaware, Novo Nordisk has lost a key U.S. patent dispute against generics maker Viatris, clearing the way for potential Wegovy® generics - using semaglutide - for obesity and diabetes treatment.

Wegovy® is a registered trademark of Novo Nordisk A/S.

SubMagna HMW

The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation.